Guang-Tao Yu Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

3/2017	Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
1/2017	T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guang-Tao Yu Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 01/2014
25	Squamous Cell Carcinoma of Head and Neck 03/2024 - 01/2014
3	Hypoxia (Hypoxemia) 01/2023 - 01/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2015
3	Carcinogenesis 01/2017 - 01/2014
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2015
2	Lymphatic Metastasis 01/2018 - 01/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 03/2017 - 01/2017
1	Hyperthermia 03/2024
1	Periodontitis 01/2024
1	Pneumonia (Pneumonitis) 01/2023
1	COVID-19 01/2023
1	Cytokine Release Syndrome 01/2023
1	Triple Negative Breast Neoplasms 01/2020
1	Bites and Stings (Sting) 01/2020
1	Starvation 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Breast Neoplasms (Breast Cancer) 04/2018
1	Inflammation (Inflammations) 01/2017
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Pleomorphic Adenoma 01/2014

Drug/Important Bio-Agent (IBA)

5	Transforming Growth Factor-beta Type I ReceptorIBA 01/2021 - 01/2015
4	NSC 74859IBA 05/2023 - 12/2015
4	Immune Checkpoint ProteinsIBA 10/2019 - 01/2016
4	Monoclonal AntibodiesIBA 01/2018 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2014
2	CalreticulinIBA 04/2024 - 04/2023
2	Adenosine (Adenocard)FDA LinkGeneric 05/2023 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2016
2	src-Family KinasesIBA 11/2018 - 03/2017
2	Dasatinib (BMS 354825)FDA Link 11/2018 - 03/2017
2	p21-Activated KinasesIBA 05/2018 - 01/2016
2	Cetuximab (Erbitux)FDA Link 03/2016 - 01/2015
1	HydrogelsIBA 04/2024
1	UCON 50-HB-5100 (F127)IBA 04/2024
1	Caspase 3 (Caspase-3)IBA 04/2024
1	Decitabine FDA Link 04/2024
1	Phosphorus (Red Phosphorus)IBA 04/2024
1	Photosensitizing Agents (Photosensitizers)IBA 04/2024
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2024
1	HMGB1 Protein (HMG1)IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 03/2024
1	ManganeseIBA 03/2024
1	GadoliniumIBA 03/2024
1	Metal-Organic FrameworksIBA 03/2024
1	glycidyl methacrylateIBA 01/2024
1	Lysine (L-Lysine)FDA Link 01/2024
1	Human Serum Albumin FDA LinkGeneric 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	FluorocarbonsIBA 01/2023
1	OxidesIBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2021
1	ChromatinIBA 01/2021
1	InterferonsIBA 01/2020
1	Therapeutic UsesIBA 10/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	leukocyte-associated immunoglobulin-like receptor 1IBA 01/2019
1	Glucose OxidaseIBA 01/2019
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2018
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Mucin-3IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	SurvivinIBA 01/2017
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	InflammasomesIBA 01/2017
1	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 01/2017
1	CTLA-4 AntigenIBA 06/2016
1	Plasminogen Activator Inhibitor 1IBA 03/2016
1	Cisplatin (Platino)FDA LinkGeneric 03/2016
1	Epidermal Growth Factor (EGF)IBA 03/2016
1	Docetaxel (Taxotere)FDA Link 03/2016
1	Fluorouracil (Carac)FDA LinkGeneric 03/2016
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2016
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	Sirolimus (Rapamycin)FDA Link 01/2014
1	Caveolin 1IBA 01/2014

Therapy/Procedure

11	Therapeutics 04/2024 - 01/2015
11	Immunotherapy 04/2024 - 12/2015
4	Drug Therapy (Chemotherapy) 04/2024 - 01/2016
2	Photochemotherapy (Photodynamic Therapy) 04/2024 - 01/2023
2	Photothermal Therapy 04/2024 - 04/2018
2	Radiotherapy 01/2023 - 01/2015
1	Induced Hyperthermia (Thermotherapy) 03/2024
1	Precision Medicine 03/2024
1	Aftercare (After-Treatment) 03/2024
1	Intravenous Administration 01/2023
1	Induction Chemotherapy 01/2017
1	Chemoradiotherapy 01/2017
1	Investigational Therapies (Experimental Therapy) 01/2017